AbbVie Inc. Financial Report: Stock & Senior Notes Overview (Feb 2025)
Here’s a summary of the key information extracted from the provided financial report section:
Company Overview
- Company Name: AbbVie Inc.
- CIK (Central Index Key): 0001551152
- Address: 1 North Waukegan Road, North Chicago, IL 60064-6400
- Phone: 847-932-7900
- Entity Listings:
- Common Stock, $0.01 Par Value listed on NYSE (Ticker: ABBV)
- Senior Notes with various maturities listed on NYSE
Financial Instruments
The report details various classes of stock and senior notes issued by AbbVie, which are significant for investors and analysts:
- Common Stock
- Par Value: $0.01
- Exchange: NYSE
- Ticker: ABBV
- Senior Notes
- 0.750% Senior Notes due 2027
- 2.125% Senior Notes due 2028
- 2.625% Senior Notes due 2028
- 2.125% Senior Notes due 2029
- 1.250% Senior Notes due 2031
- All listed on NYSE, with specific tickers (e.g., ABBV27 for the 0.750% notes).
Reporting Period
- Report Date: February 18, 2025
- The report outlines the status of stock and notes as of this date.
Key Context
- The financial figures are provided in USD and shares, indicating the nature of the instruments and their valuation.
Insights
- The presence of multiple senior note issuances with varying interest rates and maturities suggests AbbVie is managing its capital structure actively. This could indicate a strategy to balance debt obligations with investor demand for fixed-income securities.
- The consistent listing on major exchanges like NYSE underscores the liquidity and market presence of AbbVie’s securities, which is vital for investor confidence.
Conclusion
AbbVie Inc. is actively managing its equity and debt instruments, which are publicly traded and provide opportunities for investment. The structured maturity of its senior notes may reflect a strategic approach to interest rate risk and funding requirements over time.